2008
First trial batch taken
2009
Marketing operation started
2010
Introduced ASTRAL division ( 2nd Division )
2011
Introduced Donepezil (DOPEZIL ) : First time in Nepal
- WHO-GMP certificate
- Introduced PSYNO, a neuropsychiatric division
2012
Introduced Sitagliptin (GLIPTIN) – 1st time in Nepal
2013
Introduced Olmesartan (OSART) – 1st time in Nepal
2014
Received ISO 9001:2008 certificate
2014
Introduced VALID-ER – first Nepali brand of Divalproex Sodium
2015
Introduced MEGA division : Fourth division, Introduced LEVETAM-SR-First Nepali Brand of Levetiracetam
2018
ENECA-B/ TENOF / MIXAR / GLIFAZ
2018
Institution division launched
2019
CDCU Ka and Kha segregated : - LUCAST PLUS launched
2021
Launching of novel oral anticoagulant COAGRIV, our brand of Rivaroxaban. Achieved 100 Crore
